Evidence map›Paper›PMID 37248309›Full record

ArticleScientific reports2023

Multiple instance learning based classification of diabetic retinopathy in weakly-labeled widefield OCTA en face images.

Philipp Matten, Julius Scherer, Thomas Schlegl, Jonas Nienhaus, Heiko Stino, Michael Niederleithner, Ursula M Schmidt-Erfurth, Rainer A Leitgeb, Wolfgang Drexler, Andreas Pollreisz and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Advances in OCT Angiography.Translational vision science & technology · 2025
    Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Philipp Matten *Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Waehringer Guertel 18-20 (4L), 1090, Vienna, Austria. philipp.matten@meduniwien.ac.at.
Julius Scherer *Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Waehringer Guertel 18-20 (4L), 1090, Vienna, Austria.
Thomas SchleglCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna, Waehringer Guertel 18-20 (4L), 1090, Vienna, Austria.
Jonas NienhausCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna, Waehringer Guertel 18-20 (4L), 1090, Vienna, Austria.
Heiko StinoDepartment of Ophthalmology and Optometry, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Michael NiederleithnerCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna, Waehringer Guertel 18-20 (4L), 1090, Vienna, Austria.
Ursula M Schmidt-ErfurthDepartment of Ophthalmology and Optometry, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Rainer A LeitgebCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna, Waehringer Guertel 18-20 (4L), 1090, Vienna, Austria.
Wolfgang DrexlerCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna, Waehringer Guertel 18-20 (4L), 1090, Vienna, Austria.
Andreas PollreiszDepartment of Ophthalmology and Optometry, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Tilman SchmollCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna, Waehringer Guertel 18-20 (4L), 1090, Vienna, Austria.
Medical University of Vienna · ATCarl Zeiss (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic retinopathy (DR), a pathologic change of the human retinal vasculature, is the leading cause of blindness in working-age adults with diabetes mellitus. Optical coherence tomography angiography (OCTA), a functional extension of optical coherence tomography, has shown potential as a tool for early diagnosis of DR through its ability to visualize the retinal vasculature in all spatial dimensions. Previously introduced deep learning-based classifiers were able to support the detection of DR in OCTA images, but require expert labeling at the pixel level, a labor-intensive and expensive process. We present a multiple instance learning-based network, MIL-ResNet,14 that is capable of detecting biomarkers in an OCTA dataset with high accuracy, without the need for annotations other than the information whether a scan is from a diabetic patient or not. The dataset we used for this study was acquired with a diagnostic ultra-widefield swept-source OCT device with a MHz A-scan rate. We were able to show that our proposed method outperforms previous state-of-the-art networks for this classification task, ResNet14 and VGG16. In addition, our network pays special attention to clinically relevant biomarkers and is robust against adversarial attacks. Therefore, we believe that it could serve as a powerful diagnostic decision support tool for clinical ophthalmic screening.

Indexed as

Diabetes MellitusDiabetic RetinopathyAdultEarly DiagnosisFluorescein AngiographyHumansRetinal VesselsTomography, Optical Coherence

Identifiers

PMID37248309
PMCPMC10226980
OpenAlexW4378713795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.